Peter Mac Molecular Genomics Core


The Molecular Genomics Core at Peter Mac processes samples, implements and develops new genomics protocols for cancer research and translational applications. We work predominantly with Next Generation Sequencing (NGS, Illumina compatible) but also with the nCounter technology (Nanostring) for gene expression of FFPE-derived samples. We operate a Chromium iX for single-cell sequencing and the Visium (10xGenomics) and GeoMx DSP (Nanostring) for spatial transcriptomics. We specialize in custom protocols and challenging cancer samples such as low input and FFPE-derived. 


Whole-genome sequencing (WGS) Whole exome sequencing (WES) DNA targeted capture (off-the-shelf and custom panels) Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-Seq) Chromatin immunoprecipitation followed by sequencing (ChIP-seq) Methylated DNA immunoprecipitation sequencing (MeDIP-Seq) Methylation CRISPR-Seq Support in custom applications

NextSeq 500 only

3'RNA-seq RNA-Seq (polyA and ribo-depletion) RNAseq and whole exome sequencing (WES) SLAM-Seq PRO-Seq High-throughput low-cost RNA-Seq (MAC-Seq) FFPE-derived RNA Support in custom applications


Chromium iX (10xGenomics)

Illumina NextSeq Illumina NovaSeq

GeoMx DSP (Nanostring) Visium (10X Genomics)

Bravo BenchCel Workstation EpMotion

nCounter Nanostring for gene expression compatible with FFPE-derived RNA

Access Information


Tim Semple
Research Officer

General contact

Team Members


An error has occurred. This application may no longer respond until reloaded. Reload 🗙